WBA Stock Recent News
WBA LATEST HEADLINES
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Among the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell and gene therapy services.
Tommy Tuberville, a Republican Senator from the state of Alabama, disclosed 19 new stock trades on April 15th, and one trade in particular is causing big movements in the underlying stock.
Walgreens (NASDAQ: WBA ) layoffs are a hot topic on Thursday after the pharmacy company announced plans to cut jobs! The latest statement notes that Walgreens isn't revealing the number of employees who are being cut in these layoffs.
Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Walgreens has invested billions into primary care in recent years. The company is offering in-person assistance and guidance to patients.
Walgreens cut its dividend this year. The company's latest earnings numbers weren't great because even without impairment charges, Walgreens would still have reported a loss.
Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Momentum has been driving the market, led by artificial intelligence stocks, with the S&P 500 up 10% for the first quarter. However, the markets have started broadening, with financials, industrials and energy stocks also rallying.
Walgreens stock trades for less than 6 times forward earnings. The company recently narrowed its outlook for the year, and TD Cowen sees these targets as achievable.